ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
21 announcements with these filters
DCM Shriram International paid Rs. 1.94 Lakh in total fines to BSE and NSE for delayed compliance with Regulation 17(1A). The matter is now concluded.
DCM Shriram International Limited received a fine of ₹0.01 Crore from BSE and NSE for delayed compliance with Regulation 17(1A) of SEBI LODR Regulations.
DCM Shriram International Ltd reported revenue from operations of ₹108.6 Cr (-4.9% YoY) and net profit of ₹0 Cr for Q1 FY27.
DCM Shriram International will hold a board meeting on August 14, 2026, to consider and approve unaudited financial results for the quarter ended June 30, 2026.
Lala Bansidhar & Sons HUF disposed of 1,20,28,267 equity shares (13.83%) of DCM Shriram International Ltd via an off-market inter-se transfer among promoters.
Promoter Alok Bansidhar Shriram acquired 2,69,05,206 equity shares (30.92%) of DCM Shriram International Ltd via an off-market inter-se transfer.
Promoter Alok Bansidhar Shriram will acquire a 30.92% stake in DCM Shriram International via an inter-family gift, with no open offer obligation.
DCM Shriram International Ltd submitted its quarterly shareholding pattern for the period ending June 30, 2026, in compliance with SEBI Regulation 31.
DCM Shriram International ratified a Rs. 0.0059 Crore fine payment for SEBI Regulation 17(1A) non-compliance. The matter is now concluded following board observation and advisory.
DCM Shriram International concluded its 4th AGM on July 16, 2026. Members considered dividend declaration of Rs. 0.40 per share and adoption of FY26 financial statements.
DCM Shriram International received ₹0.11 Crore in fines from BSE and NSE for technical non-compliance. The company clarified the oversight and has already regularized the appointment.
DCM Shriram International submitted a revised declaration regarding its March 2026 financial results following a BSE query. The update confirms unmodified audit opinions for both standalone and consolidated results.
DCM Shriram International recommended a ₹20 per share final dividend for FY2025-26. The record date is July 6, 2026, with payment expected by mid-August.
DCM Shriram International reported audited financial results for the year ended March 31, 2026. The filing includes standalone and consolidated statements, showing full-year operational performance.
DCM Shriram International Ltd reported revenue from operations of ₹116.4 Cr (-3.2% YoY) and a net loss of ₹18.2 Cr for Q4 FY26.
DCM Shriram International reported audited FY26 results and recommended a Rs. 0.40 per share dividend. Total dividend outflow is estimated at ₹0.348 Crore.
DCM Shriram International updated its Corporate Identification Number to L17299DL2022PLC404291 following its listing on stock exchanges. This administrative change reflects the company's transition to listed status.
DCM Shriram International Ltd scheduled a board meeting on May 21, 2026. Directors will consider annual audited financial results and a final dividend declaration.
DCM Shriram International Limited submitted the share dematerialization and rematerialization certificate for the quarter ended March 31, 2026. The certificate, issued by KFIN Technologies Limited, confirms compliance with SEBI (Depositories and Participants) Regulations, 2018. This is a routine administrative disclosure with no material financial impact.
DCM Shriram International Limited has issued a Postal Ballot notice to shareholders for the appointment of several directors, including a Managing Director & CEO and Independent Directors. The ballot also seeks approval for the appointment of M/s. Chandrasekaran Associates as Secretarial Auditors for a five-year term starting April 2025.
DCM Shriram International Limited has issued a Postal Ballot Notice to seek shareholder approval for the appointment and remuneration of several key directors and secretarial auditors. The resolutions include the appointment of Mr. Alok Bansidhar Shriram as MD & CEO for five years. Remote e-voting commences on April 13, 2026, and concludes on May 12, 2026.